The evolution of adaptiveness: balancing speed and evidence
Nat Rev Drug Discov
.
2018 Dec;17(12):845-846.
doi: 10.1038/nrd.2018.90.
Epub 2018 Jul 6.
Authors
Hans-Georg Eichler
1
,
Richard Barker
2
,
Nicola Bedlington
3
,
Jacoline C Bouvy
4
,
André W Broekmans
5
,
Anna Bucsics
6
,
Francesca Cerreta
1
,
Solange Corriol-Rohou
7
,
Alicia Granados
8
,
Yann Le Cam
9
,
Ad Schuurman
10
Affiliations
1
European Medicines Agency (EMA), London, UK.
2
Centre for the Advancement of Sustainable Medical Innovation (CASMI), Oxford, UK.
3
European Patients Forum (EPF), Brussels, Belgium.
4
National Institute for Health and Care Excellence (NICE), London, UK.
5
Lygature, Utrecht, Netherlands.
6
Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA), Vienna, Austria.
7
AstraZeneca, Paris, France.
8
Sanofi, Barcelona, Catalunya, Spain.
9
EURORDIS, Paris, France.
10
National Health Care Institute (ZIN), Diemen, Netherlands.
PMID:
29977052
DOI:
10.1038/nrd.2018.90
No abstract available
MeSH terms
Delivery of Health Care / economics
Drug Industry / economics*
Europe
Health Occupations / economics
Humans
Marketing / economics
Pharmaceutical Preparations / economics*
Substances
Pharmaceutical Preparations